We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
-7.98%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$369M
AUM Growth
+$24.5M
Cap. Flow
+$25.6M
Cap. Flow %
6.94%
Top 10 Hldgs %
100%
Holding
8
New
4
Increased
–
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
SPRO icon
Spero Therapeutics
SPRO
+$13.7M
2
DNLI icon
Denali Therapeutics
DNLI
+$10.2M
3
XFOR icon
X4 Pharmaceuticals
XFOR
+$6.34M
4
XYZ
Block Inc
XYZ
+$1.08M

Top Sells

Rank Stock Value
1
CLDR
Cloudera, Inc.
CLDR
+$5.69M

Sector Composition

Rank Sector Weight
1 Healthcare 15.33%
2 Communication Services 10.42%
3 Technology 6.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARRS
1
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$249M 67.63%
9,703,500
– –
SNAP icon
2
Snap
SNAP
$7.89B
$38.3M 10.38%
2,618,548
– –
XFOR icon
3
X4 Pharmaceuticals
XFOR
$375M
$34.6M 9.38%
+2,508
New +$6.34M
CLDR
4
DELISTED
Cloudera, Inc.
CLDR
$23.4M 6.34%
1,415,227
-353,806
-20% -$5.69M
SPRO icon
5
Spero Therapeutics
SPRO
$67.7M
$13.1M 3.55%
+1,112,473
New +$13.7M
DNLI icon
6
Denali Therapeutics
DNLI
$3.65B
$8.86M 2.4%
+566,666
New +$10.2M
XYZ
7
Block Inc
XYZ
$48.4B
$1.02M 0.28%
+29,400
New +$1.08M
TWTR
8
DELISTED
Twitter, Inc.
TWTR
$157K 0.04%
6,533
– –

Similar funds

JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
MGP
Metis Global Partners San Diego, California $4.07B AUM 30.82% 1-Year Est. Return

Alphabet Inc's Q4 2017 Portfolio in Review

As of Q4 2017, Alphabet Inc held 8 positions worth $369M, up 7.1% from $344M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Alphabet Inc deployed $25.6M of net new capital in Q4 2017, opening 4 new positions. Its largest new stake was Spero Therapeutics: 1,112,473 shares worth $13.1M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, followed by Communication Services and Technology.

On the sell side, the largest reduction was Cloudera, Inc., an estimated $5.69M trimmed.

  • Alphabet Inc's largest Q4 2017 buy was Spero Therapeutics: 1,112,473 shares worth $13.1M.
  • Alphabet Inc's biggest Q4 2017 reduction was Cloudera, Inc., cutting an estimated $5.69M.
  • Alphabet Inc's ten largest holdings make up 100% of its $369M portfolio in Q4 2017.
  • Alphabet Inc opened 4 new positions and closed 0 in Q4 2017.
  • Alphabet Inc's portfolio value rose 7.1% quarter-over-quarter to $369M.

Based on Alphabet Inc's 13F filing for Q4 2017, filed 15 Nov 2022.